Ironwood Pharmaceuticals ... (IRWD)
NASDAQ: IRWD
· Real-Time Price · USD
1.07
-0.02 (-1.83%)
At close: Aug 14, 2025, 3:59 PM
1.09
1.40%
Pre-market: Aug 15, 2025, 09:22 AM EDT
Ironwood Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 92.85M | 108.48M | 88.56M | 88.21M | 105.52M | 121.54M | 92.15M | 110.16M | 175.32M | 740.34M | 656.2M | 574.19M | 504.37M | 593.37M | 620.13M | 574.28M | 492.7M | 438.47M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 510K | 510K | 485K | 15.07M | 14.92M | 14.77M | 14.63M | 24.48M | 24.34M | 24.19M | 35.39M |
Other Long-Term Assets | 5.15M | 5.54M | 5.92M | 6.29M | 4.26M | 3.4M | 3.61M | 3.82M | 4.43M | 1.3M | 15.92M | 15.79M | 15.65M | 15.58M | 25.48M | 25.19M | 25.07M | 924K |
Receivables | 86.17M | 39.77M | 81.89M | 76.2M | 58.11M | 72.02M | 129.12M | 124.55M | 118.99M | 115.75M | 115.46M | 116.55M | 102.36M | 105.52M | 114.04M | 101.77M | 102.25M | 87.15M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.25M | 1.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 12.73M | 12.33M | 11.92M | 14.19M | 14.55M | 14.62M | 12.01M | 18.9M | 23.29M | 10.28M | 8.96M | 1.25M | 1.25M | 2.68M | 11.05M | 9.1M | 13M | 1.74M |
Total Current Assets | 191.75M | 160.58M | 182.37M | 178.6M | 178.18M | 208.17M | 233.29M | 253.61M | 317.6M | 866.37M | 780.63M | 698.99M | 617.83M | 710.1M | 745.23M | 695.37M | 620.27M | 538.25M |
Property-Plant & Equipment | 14.13M | 14.88M | 15.52M | 16.23M | 16.89M | 17.5M | 18.17M | 18.59M | 19.2M | 19.69M | 20.31M | 21.02M | 21.66M | 22.26M | 22.93M | 23.58M | 24.08M | 24.78M |
Goodwill & Intangibles | 2.45M | 2.66M | 2.86M | 3.07M | 3.27M | 3.48M | 3.68M | 3.89M | 4.1M | -485K | -15.07M | -14.92M | -14.77M | -14.63M | -24.48M | -24.34M | -24.19M | n/a |
Total Long-Term Assets | 151.19M | 166.63M | 168.54M | 210.91M | 217.44M | 230.65M | 237.78M | 270.45M | 285.62M | 288.9M | 319.89M | 341.35M | 357.86M | 373.28M | 381.7M | 384M | 386.95M | 61.1M |
Total Assets | 342.95M | 327.21M | 350.91M | 389.52M | 395.62M | 438.82M | 471.07M | 524.06M | 603.22M | 1.16B | 1.1B | 1.04B | 975.69M | 1.08B | 1.13B | 1.08B | 1.01B | 599.34M |
Account Payables | 1.39M | 5.83M | 2.13M | 3.24M | 3.23M | 6.22M | 7.83M | 4.7M | 3.5M | 118K | 483K | 795K | 317K | 532K | 935K | 414K | 466K | 842K |
Deferred Revenue | n/a | 1.8M | 2.03M | n/a | n/a | 1.9M | 1.24M | n/a | n/a | n/a | n/a | n/a | 15.1M | n/a | 39.46M | 21.8M | 15.73M | 17.74M |
Short-Term Debt | 202.55M | 3.2M | 3.19M | 3.17M | 3.16M | 199.8M | 199.56M | 199.32M | 199.08M | 3.08M | n/a | 3.05M | 3.07M | 120.58M | 116.86M | 114.83M | 112.85M | 3.14M |
Other Current Liabilities | 28.58M | 10.17M | 1.79M | 20.14M | 22.15M | 8.76M | 43.16M | 48.48M | 67.72M | 13.38M | 9.71M | 13.24M | 10.51M | 12.81M | 21.41M | 13.54M | 7.2M | 8.54M |
Total Current Liabilities | 232.53M | 48.1M | 38.85M | 49.38M | 45.51M | 252.44M | 276.1M | 280.58M | 305.39M | 23.84M | 25.52M | 27.12M | 23.3M | 147.4M | 161.7M | 145.69M | 134.37M | 23.6M |
Long-Term Debt | 385M | 584.16M | 583.99M | 598.82M | 623.65M | 473.48M | 498.31M | 523.14M | 597.97M | 412.76M | 396.25M | 412.94M | 413.02M | 395.05M | 337.33M | 333.21M | 329.15M | 455.94M |
Other Long-Term Liabilities | 22.47M | 17.29M | 17.11M | 39.77M | 34.74M | 29.41M | 28.41M | 30.95M | 31.04M | -4.28M | 9.77M | -7.86M | -11.08M | 5.11M | 3.5M | 1.59M | 12.54M | -10.25M |
Total Long-Term Liabilities | 418.58M | 613.17M | 613.4M | 651.47M | 671.84M | 516.89M | 541.27M | 569.16M | 644.61M | 424.58M | 422.62M | 422.16M | 419.51M | 418.19M | 359.32M | 353.74M | 361.09M | 465.55M |
Total Liabilities | 442.97M | 661.27M | 652.24M | 700.85M | 717.35M | 769.34M | 817.37M | 849.74M | 950M | 448.43M | 448.14M | 449.28M | 442.81M | 565.6M | 521.02M | 499.43M | 495.46M | 489.15M |
Total Debt | 598.67M | 599.08M | 599.48M | 614.87M | 640.26M | 690.42M | 715.54M | 740.65M | 815.75M | 415.84M | 415.92M | 415.99M | 416.08M | 536.76M | 475.8M | 470.13M | 464.56M | 459.08M |
Common Stock | n/a | 162K | 160K | 160K | 160K | 159K | 156K | 156K | 156K | 155K | 154K | 153K | 153K | 155K | 162K | 163K | 163K | 162K |
Retained Earnings | n/a | -1.74B | -1.7B | -1.7B | -1.7B | -1.7B | -1.7B | -1.7B | -1.71B | -650.66M | -696.38M | -745.24M | -795.56M | -832.64M | -937.61M | -978.98M | -1.03B | -1.43B |
Comprehensive Income | n/a | 294K | 923K | -2.05M | -470K | -922K | -3.03M | -752K | -0.00 | 0.00 | 0.00 | n/a | n/a | n/a | -0.00 | n/a | -0.00 | 1.54B |
Shareholders Equity | -308.16M | -334.05M | -301.33M | -311.33M | -321.73M | -330.52M | -346.3M | -323.22M | -345.7M | 706.85M | 652.38M | 591.06M | 532.88M | 517.78M | 605.91M | 579.94M | 511.76M | 110.19M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 510K | 510K | 485K | 15.07M | 14.92M | 14.77M | 14.63M | 24.48M | 24.34M | 24.19M | 35.39M |